OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)

View On IPO.GOV.AU

Registered: Registered/protected

Last updated on 19 Oct 2023

Owner Info

Bristol-Myers Squibb Company

Route 206 & Province Line Road

Princeton, New Jersey 08543, UNITED STATES OF AMERICA

Serial Number

2304108 filed on 29 Sept 2022

Correspondent

Spruson & Ferguson

GPO Box 3898,

Sydney, NSW, 2001 AUSTRALIA,

OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)

Classification Information

2304108

29 Sept 2022

29 Sept 2032

FIGURATIVE

Status Date	Action Taken
19^th Oct 2023	Customer Amendment Made correspondence sent
19^th Oct 2023	Owner name details updated
6^th Oct 2023	Amendment to Amend Owner Requested
8^th May 2023	IP Right Registered correspondence sent
8^th May 2023	IP Right Registration Published
8^th May 2023	Status change to Registered/Protected
1^st Mar 2023	Application Accepted correspondence sent
1^st Mar 2023	IP Right has been Examined
1^st Mar 2023	IP Right Acceptance Published
3^rd Feb 2023	Early Acceptance Notice correspondence sent